FDA Inspection 1048111 — Cedars-Sinai Medical Center

Cedars-Sinai Medical Center — FEI 2073862

The FDA completed an inspection of Cedars-Sinai Medical Center on Feb 27, 2018 in West Hollywood, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 27, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
West Hollywood, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.